BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7696314)

  • 1. Dual effect of synthetic plasmin substrates on plasminogen activation.
    Kolev K; Owen WG; Machovich R
    Biochim Biophys Acta; 1995 Mar; 1247(2):239-45. PubMed ID: 7696314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
    Machovich R; Owen WG
    Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of tissue plasminogen activator and urokinase as determined with synthetic chromogenic substrates.
    Matsuo O; Sakai T; Takakura Y; Mihara H
    Jpn J Physiol; 1983; 33(6):1031-7. PubMed ID: 6687071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
    Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
    Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS
    Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
    Petersen LC; Brender J; Suenson E
    Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen.
    Léránt I; Kolev K; Gombás J; Machovich R
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):311-20. PubMed ID: 10899632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
    Gilboa N; Villannueva GB; Fenton JW
    Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of angiostatins on activity of the plasminogen/plasminogen activator system.
    Aisina RB; Mukhametova LI; Gulin DA; Levashov MY; Prisyazhnaya NV; Gershkovich KB; Varfolomeyev SD
    Biochemistry (Mosc); 2009 Oct; 74(10):1104-13. PubMed ID: 19916923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of native and denatured whey proteins on plasminogen activator activity.
    Rippel KM; Nielsen SS; Hayes KD
    J Dairy Sci; 2004 Aug; 87(8):2344-50. PubMed ID: 15328255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of inhibitory effect of angiostatin on plasminogen activation by its physiologic activators].
    Aĭsina RB; Mukhametova LI; Prisiazhnaia NV; Gulin DA; Levashov MIu; Gershkovich KB
    Bioorg Khim; 2011; 37(3):319-26. PubMed ID: 21899046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activation kinetics of mammalian plasminogens.
    Wohl RC; Sinio L; Summaria L; Robbins KC
    Biochim Biophys Acta; 1983 May; 745(1):20-31. PubMed ID: 6682680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
    Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
    Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denatured proteins as cofactors for plasminogen activation.
    Machovich R; Owen WG
    Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
    Ellis V; Scully MF; Kakkar VV
    J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of activity assays for tissue plasminogen activator.
    Tang JC; Li S; McGray P; Vecchio A
    Ann N Y Acad Sci; 1984; 434():536-40. PubMed ID: 6441502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of single chain urokinase by small peptides.
    Higazi A al-R ; Cines D
    Thromb Res; 1996 Nov; 84(4):243-52. PubMed ID: 8948049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.